Ultragenyx Pharmaceutical Inc (RARE)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
0/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)42%
Our last 30 days of resolved calls came true 29% of the time.See the track record →
Price
$12.88
1 day
-1.45%
1 week
-8.67%
1 month
-48.16%
1 year
-54.93%
Market cap
$1.3B
Company fundamentals
EPS (TTM)
$-5.84
Debt / Equity
90.54
Current ratio
1.73
Operating margin
-73.7%
Net margin
-81.7%
Gross margin
83.1%
Return on equity
-414.2%
Revenue growth (YoY)
17.5%
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
Example trade plan · illustrative risk framework
Entry zone
$12.69–$13.14
Stop-loss (exit)
$11.59 −10%
Target (exit)
$15.46 +20%
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
Why it ranks: factor attribution
- QualityRevenue growing 18% y/y-4
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →